GPX4 and acute myeloid leukemia: This possibility is supported by clinical data suggesting that mRNA expression of GSH-related antioxidant genes (including GSS, GPX4, or GSTA1) correlated with poor overall survival in human AML (Cancer Genome Atlas Research et al., 2013) (Figures S4B–S4E).